All In Biotech

Free tool

FAERS Monitor: Voriconazole

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208562 or its brand name (Voriconazole, Voriconazole). Reports on generic versions are filed under their own applications.

Reports

22,090

Serious

20,722

94% of reports

Hospitalization

9,197

Death reported

6,438

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,031
  • off label use2,121
  • drug interaction2,063
  • pyrexia1,074
  • pneumonia911
  • bronchopulmonary aspergillosis897
  • condition aggravated879
  • aspergillus infection866
  • febrile neutropenia756
  • death727
  • respiratory failure692
  • multiple organ dysfunction syndrome667
  • product use in unapproved indication667
  • neutropenia618
  • septic shock602

Reports by year received

View as table
YearReports
200489
2005108
2006113
2007193
2008210
2009294
2010359
2011388
2012429
2013495
2014459
2015570
2016798
20171,417
20181,785
20191,949
20201,988
20211,919
20221,945
20231,831
20241,790
20251,733
20261,227

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,032,069 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
aspergillus infectionSignal866144.6134.7107,092
bronchopulmonary aspergillosisSignal897124.4116.297,042
multiple organ dysfunction syndromeSignal66722.921.313,661
septic shockSignal60213.312.36,782
drug interactionSignal2,06312.512.021,759
febrile neutropeniaSignal75611.010.26,780
respiratory failureSignal6929.18.54,959
neutropeniaSignal6184.34.01,590
pyrexiaSignal1,0743.02.81,412
drug ineffectiveSignal4,0312.92.85,403
condition aggravatedSignal8792.82.6995
pneumoniaSignal9112.72.5973
product use in unapproved indicationSignal6672.62.4642
off label useSignal2,1212.32.21,638
death7270.80.736

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.